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Mutants of the Torpedo nicotinic acetylcholine receptor in which each of the putative transmembrane seg- 
ments of the a-subunit is replaced by the hydrophobic transmembrane segment of the vesicular stomatitis 
virus glycoprotein or of the human interleukin-2 receptor have been produced in Xenopus oocytes by cDNA 
manipulations. Functional analysis of these mutants shows that the ydrophobic segment M4 can be re- 
placed by foreign transmembrane sequences without loss of channel activity. It is also suggested that the 
hydrophobic segments Ml, M2 and M3 and the amphipathic segment MA are important for efficient ex- 
pression of the acetylcholine receptor on the cell surface and that the specific amino acid sequence of seg- 
ment M2 may be involved in channel activity. 
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1. INTRODUCTION 
The nicotinic acetylcholine receptor from 
Torpedo electroplax is composed of four kinds of 
subunits assembled in a molar stoichiometry of 
~~$3~8 [l]. The primary structures of the four 
subunits of the Torpedo californica AChR, de- 
duced from the cDNA sequences [2-51, exhibit 
conspicuous amino acid sequence homology. This 
observation, as well as electron image analysis [6], 
supports the notion that the AChR subunits are 
oriented in a pseudosymmetric fashion across the 
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membrane, thus forming the ionic channel. The 
carboxy-terminal half of each subunit contains 
four strongly hydrophobic segments (Ml -M4) 
[2-51, which are considered to traverse the mem- 
brane. An amphipathic segment (MA) [7,8] and 
two additional segments [9] have been proposed as 
potential membrane-spanning regions. 
The combination of cDNA expression and site- 
directed mutagenesis provides a powerful tool for 
studying the structure-function relationship of the 
AChR [lo-161. The results of deletion mapping 
suggest that segments Ml, M2, M3, M4 and MA 
are involved directly or indirectly in the formation 
of the ionic channel [l 1,171. These segments may 
constitute part of the channel wall or may alter- 
natively be implicated in the correct folding, 
assembly or transport of the subunits. The present 
investigation deals with the question as to whether 
the putative transmembrane segments of the 
AChR a-subunit can be functionally replaced by 
hydrophobic transmembrane segments from other 
proteins. 
56 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/87/$3.50 0 1987 Federation of European Biochemical Societies 
Volume 222, number 1 FEBS LETTERS September 1987 
2. MATERIALS AND METHODS 
cDNAs encoding T. californica AChR a-subunit 
mutants with substitutions were constructed using 
synthetic oligodeoxyribonucleotides prepared with 
an automatic DNA synthesizer (Applied 
Biosystems) and restriction endonuclease-cleaved 
DNA fragments from the plasmids pSPcu, pSP&, 
pSP&NA and pSP&A [ 1 l] and from pSPa4 and 
pSPcu5 (see below). Some silent mutations were in- 
troduced by the strategies used (see below). The 
double-stranded oligonucleotides GP-1 ‘and GP-2 
were synthesized to encode the transmembrane 
segment of the VSV glycoprotein [18] (nucleotide 
residues 1416- 1475 encoding amino acid residues 
463-482), and the double-stranded oligonucleo- 
tides IR-1, IR-2 and IR-3 to encode the transmem- 
brane segment of the human interleukin-2 receptor 
[ 19,201 (nucleotide residues 895-95 1 encoding 
amino acid residues 220-238; for the residue 
numbers, see [20]). These synthetic oligonucleo- 
tides differed from the original cDNAs as follows: 
GP-1, TCA for nucleotides 1416-1418, G for 
1421, 1451 and 1460, C for 1424, 1448, 1449 and 
1463, AAGC for 1427-1430 and A for 1469; 
GP-2, identical with GP-1 except A for 1421 and 
1475 and T for 1473; IR-1, G for 897 and 933 C for 
900 and 945, and A for 903; IR-2, G for 897 and 
933, C for 900 and A for 903; IR-3, G for 897 and 
933 and C for 900. The plasmids constructed dif- 
fered from the parental plasmids (given in paren- 
theses) as follows (nucleotide numbers refer to 
those of the T. californica AChR a-subunit cDNA 
[2]); pSPcu4 (pSP& [ll]), C for nucleotides 1113, 
1122,1128,1143 and 1146, G for 1149, Tfor 1155, 
GAGCTC for 1173-1178 and the junctional se- 
quence between the 3 ’ -end of the a-subunit cDNA 
and the EcoRI site of the vector (referred to 
hereafter as the junctional sequence) taken from 
pSPl% [ll]; pSPcu5 (pSPc~4), C for 1209; pSPa- 
Ml-GP (pSPa), GP-2 for 631-711 and the junc- 
tional sequence from pSPEcu; pSPcuM2-GP 
(PSPCK), GP-1 for 727-783, C for 717, 789 and 
801, T for 792 and G for 795, 798 and 804; 
pSPcuM3-GP (pSPcu), GP-1 for 829-894, G for 
810, 825, 930 and 936, A for 813, 816 and 903, C 
for 822 and 939, GTCG for 909-912 and T for 
927; pSPcuMCGP (pSPcuS), GP-1 for 1225-1281, 
C for 1215 and T for 1224; pSPcrMA-GP (pSPa4), 
GP-1 for 1114-l 164 and A for 1170; pSPcvMl-IR 
(pSPa), IR-1 for 631-711, C for 627 and_ the 
junctional sequence from pSPEcu; pSPaMZIR 
(pSPa), IR-2 for 727-783, C for 717 and 801, G 
for 720, 795, 798 and 804 and the junctional 
sequence from pSP&; pSPaM3-IR (pSPa), IR-1 
for 829-894, G for 810, 825, 930 and 936, A for 
813, 816 and 903, C for 822 and 939, GTCG for 
909-912 and T for 927; pSPaMCIR (pSPaS), IR-3 
for 1225-1281; pSP&MA-IR (pSPaS), IR-2 for 
1114-l 164. The plasmids pSPcrM4-17, pSPa- 
M4- 15, pSPaM6 14, pSP@MC 11 and pSPcuM4-9, 
which carried cDNAs encoding a-subunit mutants 
with deletions, were constructed as in [ 111. All the 
constructs were confirmed by sequence analysis 
[21] of the region encompassing the mutation. The 
construction of the plasmids pSPaA224-237, 
pSPaA249-257, pSPaA279-284, pSPaA355-389, 
pSPaA366-389, pSPaA371-377, pSPc~A376-383, 
pSPc~A376-389, pSPmA382-389 and 
pSPcrA409-420 has been described [ 111. 
mRNAs encoding wild-type and mutant AChR 
subunits were synthesized in vitro as in [ 11,151, us- 
ing EcoRI-cleaved plasmids, except that the 
plasmid pSPy was cleaved with SmaI. Xenopus 
laevis oocytes were injected with the wild-type or a 
mutant cu-subunit-specific mRNA, combined with 
the wild-type P-, y- and S-subunit-specific mRNAs 
(final concentrations, 100, 50, 50 and 50 ng/pl, 
respectively; average volume injected per oocyte, 
about 40 nl). The oocytes were incubated [16] for 
2 days before being tested. The procedures for 
preparation of cell extracts [16], assay of 1251~- 
BTX binding activity in the cell extract [ 1 l] and on 
the cell surface [13], labelling with L- 
[“Slmethionine, immunoprecipitation and SDS- 
polyacrylamide gel electrophoresis of AChR 
subunits [l l] and measurement of ACh-activated 
whole cell currents [16] have been described. 
3. RESULTS 
We constructed cDNAs encoding T. californica 
AChR a-subunit mutants in which each of the 
hydrophobic segments Ml-M4 or the amphipathic 
segment MA was replaced by the transmembrane 
segment of the VSV glycoprotein 1181 or of the 
human interleukin-2 receptor [19,20]. The LY- 
subunit mutants containing the 20-amino-acid 
transmembrane segment of the VSV glycoprotein 
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Fig. 1. (A-C) Fluorograms of SDS-polyacrylamide gel 
electrophoresis of subunit polypeptides of mutant 
AChRs formed in Xenopus oocytes. For each mutant 
AChR and the wild-type AChR, two lanes bracketed 
together are presented, of which the left lane shows the 
immunoprecipitate obtained with rabbit antiserum to 
the T. californica AChR and the right lane a control 
immunoprecipitate obtained with non-immunized rabbit 
serum. The positions to which the LY-, @-, y- and 6- 
subunits of the purified T. californica AChR migrated 
are indicated. The r-subunit formed in oocytes migrated 
faster than that of the purified native AChR; this may 
be due to a difference in glycosylation or other 
processing events in vivo or to proteolytic modification 
during the isolation procedure [lo]. All the a-subunit 
mutants with a deletion show an electrophoretic mobility 
different from that expected from their molecular 
masses [11,22]. 
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Table 1 
Functional properties of AChR mutants with altered a-subunit 
September 1987 
a-Subunit ‘251~-BTX binding 
(fmol per oocyte) 
Whole-cell current 
(nA) 
Surface Extract 
Wild type 
(uMI-GP 
aM2-GP 
cuM3-GP 
CYMA-GP 
(YM~-GP 
crMl-IR 
(YM~-IR 
c~M3-IR 
crMA-IR 
crM4;IR 
cuM4-17 
cuM4-15 
cuM4-14 
(YM~- 11 
cuM4-9 
7.4 f 4.1 (30) 
ND (9) 
ND (9) 
ND (9) 
ND (9) 
0.1 + 0.1 (9) 
ND (8) 
0.6 f 0.5 (9) 
ND (8) 
ND (8) 
3.4 f 2.3 (10) 
2.4 f 1.5 (3) 
3.4 + 1.6 (3) 
ND (3) 
ND (3) 
ND (3) 
43.6 + 14.3 (19) 189 f 169 (2281230) 
3.2 + 2.2 (6) ND (O/60) 
34.8 + 16.6 (6) ND (O/60) 
16.5 + 5.2 (7) ND (O/60) 
8.2 + 4.8 (7) ND (O/60) 
34.4 * 10.3 (7) 62 f 107 (52/60) 
0.02 f 0.02 (5) ND (O/40) 
44.5 f 20.8 (5) ND (O/40) 
26.4 + 6.3 (5) ND (O/40) 
4.1 + 2.5 (5) ND (O/40) 
43.9 + 10.2 (6) 2080 f 2480 (SO/SO) 
23.3 f 6.6 (3) 24 f 23 (27/30) 
29.1 + 12.7 (3) 1490 * 1120 (30/30) 
19.6 f 6.6 (3) 0.1 * 0.7 (l/30) 
5.1 + 1.8 (3) ND (O/30) 
12.6 + 5.4 (3) ND (O/30) 
a 11 + 15 nA (19/30) in response to 1OpM ACh 
Data are given as means f SD. Numbers in parentheses indicate the number of 
experiments for “‘I-~u-BTX binding activity or the number of responsive 
oocytes/number of oocytes tested for ACh response. Whole-cell currents represent 
membrane currents activated by bath application of 1 ,uM ACh at - 70 mV membrane 
potential. Our detectable limits were -0.1 fmol per oocyte for ‘251~-BTX binding 
activity on the cell surface, -0.01 fmol per oocyte for “‘1~-BTX binding activity in 
the cell extract and -3 nA for ACh response. The means for ACh-activated currents 
were calculated by taking the value for unresponsive oocytes as zero. ND, not 
detectable. When the concentration of 1251_(y-BTX used for the assay was reduced to 
0.2 nM, the ‘251+BTX binding activities in the cell extract of the mutant AChRs 
(except for the AChR with aMl-IR) as well as of the wild-type AChR were 38-55% 
of the activities measured with 2 nM rZ51-~-BTX, suggesting that the apparent binding 
affinity for ‘251-(r-BTX was not essentially affected by the mutations. The extent of 
inhibition of rz51_ry-BTX binding by 0.5 mM carbamylcholine was 42-57070 for the 
mutant AChRs (except for the AChR with cuMl-IR) as well as for the wild-type AChR, 
suggesting that the apparent binding affinity for the agonist was not substantially 
affected by the mutations 
(SSIASFFFIIGLIIGLFLVL) in place of seg- 
ment M 1 (PLYFVVNVIIPCLLFSFLTGLVFY LP- 
T), M2 (MTLSISVLLSLTVFLLVIV), M3 (YML- 
FTMIFVISSIIITVVVINT), M4 (ILLCVFMLICII- 
GTVSVFA) or MA (VKSAIEGVKYIAEHMKS) 
are designated as cuMl-GP, (YM~-GP, aM3-GP, 
aM4-GP and aMA-GP, and the corresponding 
mutants containing the 19-amino-acid transmem- 
brane segment of the human interleukin-2 receptor 
(VAVAGCVFLLISVLLLSGL) as cuMl-IR, (uM2- 
IR, aM3-IR, aM4-IR and aMA-IR, respectively. 
Each of the mutant cY-subunit-specific mRNAs 
synthesized with the respective cDNA templates, 
combined with the wild-type ,&, y- and S-subunit- 
specific mRNAs, was injected into Xenopus 
oocytes. The amounts of individual AChR sub- 
units formed in the oocytes were estimated by 
labelling the polypeptides with [35S]methionine, 
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followed by immunoprecipitation and SDS- 
polyacrylamide gel electrophoresis. Densitometric 
scanning of the resulting fluoiograms (fig. IA and 
B) showed that, for all the mutant AChRs with a 
substitution in the a-subunit, there were sufficient 
concentrations of the four subunit polypeptides (at 
least 10% of the wild type) to allow the assay of 
functional parameters for the AChR. 
As indicated in table 1, oocytes implanted with 
most of the mutant AChRs with a substitution in 
the a-subunit exhibited ‘251-~-BTX binding ac- 
tivities in the cell extract comparable to the wild- 
type activity, whereas the mutant AChR with 
aMl-IR showed a markedly reduced activity, 
which was much lower than expected from the con- 
centrations of the subunit polypeptides found. The 
relatively low a-BTX binding activities of some 
other mutants (for example, the AChR with 
,zMl-GP or aMA-IR) can roughly be accounted 
for by the observed decreases in the amounts of the 
subunit polypeptides (see 1161). Table 1 also shows 
that oocytes implanted with the mutant AChR 
containing cuM2-IR, crMCIR or cuM4-GP exhibited 
“‘1-cz-BTX binding activities on the cell surface, 
which were diminished to various extents, 
however, as compared with the wild-type activity. 
In contrast, no cu-BTX binding activity was detec- 
table on the surface of oocytes implanted with the 
other mutant AChRs carrying a substitution in the 
a-subunit, despite the presence of significant ac- 
BTX binding activities in the cell extract (except 
for the AChR with cuMl-IR). 
The ACh responses of oocytes implanted with 
the mutant AChRs with a substitution in the cz- 
subunit were measured under voltage clamp at 
- 70 mV membrane potential, using bath applica- 
tion of ACh (table 1). Oocytes implanted with the 
mutant AChR containing aM4-IR or cuM6GP 
responded to 1 FM ACh; the currents being much 
larger than expected from the a-BTX binding ac- 
tivities found on the cell surface. In contrast, no 
detectable response (c-3 nA) was observed for 
oocytes implanted with the other mutant AChRs 
carrying a substitution in the a-subunit even after 
application of 3 (or 10) PM and 100 PM ACh. In 
view of the significant cr-BTX binding activity 
found on the surface of oocytes implanted with the 
mutant AChR containing aM2-IR (0.6 fmol per 
oocyte), a similar amount of the wild-type AChR 
was expressed on the surface of oocytes (0.8 fmol 
60 
per oocyte) by injecting lo-fold smaller amounts of 
the four subunit-specific mRNAs. These oocytes 
responded clearly to ACh, the currents activated 
by 1, 10 and 1OOpM ACh being 29, 910 and 
4150 nA, respectively (means of 20 oocytes, six of 
which failed to respond to 1 PM ACh). 
We next examined the effect of shortening of 
segment M4 of the m-subunit on AChR function. 
By introducing internal deletions into the cDNA, 
segment M4 of the a-subunit, composed of 19 
amino acid residues (see above), was shortened by 
2, 4, 5, 8 and 10 amino acids to generate the 
mutants mM4-17 (in which CII was changed to A), 
cuM615 (MLICII to IA), mM4-14 (MLICII to A), 
cyM4-11 (CVFMLICII to A) and cuM4-9 
(LLCVFMLICII to A), respectively. These dele- 
tions did not strongly affect either the amounts of 
the subunit polypeptides found or the a-BTX 
binding activity in the cell extract (fig. 1C and table 
1). As shown in table 1, the decrease in the length 
of segment M4 to 17 (cuM4-17) or 15 amino acids 
(aM4-15) did not substantially prevent the expres- 
sion of functional AChR on the cell surface; the 
current measured for the AChR with aM4-15 was 
much larger than expected from the a-BTX 
binding activity on the cell surface. The shortening 
of segment M4 to 11 (aM4-11) or 9 amino acids 
@M4-9) abolished, however, the o-BTX binding 
activity on the cell surface as well as the response 
to ACh (1, 10 and 100 pM); similarly, neither LY- 
BTX binding activity on the cell surface nor ACh 
response was detected for oocytes implanted with 
the AChR containing another a-subunit mutant 
with segment M4 of 9 amino acids in length 
@A409-420 [ll]; ILLCVFMLICII to EL), despite 
the significant a-BTX binding activity found in the 
cell extract [ 111. Oocytes implanted with the AChR 
containing the a-subunit mutant with segment M4 
of 14 amino acids in length ((uM4-14) showed no 
detectable cu-BTX binding activity on the cell sur- 
face, but responded weakly to ACh. 
Oocytes implanted with the AChRs containing 
a-subunit mutants with a deletion in segment Ml, 
M2, M3 or MA [l l] were also tested for cu-BTX 
binding activity on the cell surface and for 
response to bath-applied ACh. An internal dele- 
tion in segment Ml, M2 or M3 of the a-subunit 
@A224-237, aA249-257 and ~A279-284 [ll], 
respectively) abolished the a-BTX binding activity 
on the cell surface as well as the response to ACh 
Volume 222. number 1 FEBS LETTERS September 1987 
(1, 10 and 100 PM), despite the fact that significant 
cu-BTX binding activities were found in cell ex- 
tracts from oocytes implanted with the AChRs 
containing these a-subunit mutants except for 
aA224-237 [ll]. On the other hand, oocytes im- 
planted with the AChRs containing a-subunit 
mutants with a deletion of part or all of segment 
MA (aA355--389, cud366-389, uA371-377, 
cud376-383, cud376-389 and aA382-389 [ll]) ex- 
hibited low cr-BTX binding activities on the cell 
surface (0.1-0.5 fmol per oocyte, mean of 3-4 ex- 
periments for each mutant AChR); the a-BTX 
binding activities in the cell extract were com- 
parable to the wild-type activity [l 11. These 
oocytes showed virtually no response to 1 PM 
ACh, but most or all (68-100%) of the oocytes im- 
planted with each of these mutant AChRs respond- 
ed to 1OrM ACh, the average currents (from 
20-30 oocytes each) ranging from 14 to 131 nA. 
Using ionophoretic application of ACh, we pre- 
viously observed that all or some of oocytes 
implanted with the mutant AChR containing 
cud355-389, aA366-389 or aA371-377 responded 
to ACh, whereas oocytes implanted with the mu- 
tant AChR containing aA376-383, cud376-389 or 
cud382-389 showed no detectable response [ll]. 
This difference can be accounted for principally by 
the use of bath application of ACh in the present 
study. The absence of detectable ACh response in 
oocytes implanted with the AChRs containing the 
a-subunit mutants with a deletion in segment M 1, 
M2, M3 or M4 (segment M4 of 9 or 11 amino acids 
in length) confirms our previous results [ 111. 
4. DISCUSSION 
The present investigation shows that the 
hydrophobic segment M4 of the AChR a-subunit 
can be replaced by foreign hydrophobic transmem- 
brane sequences without loss of channel activity. 
This finding suggests that the sequence require- 
ment for segment M4 is not strict, provided that its 
hydrophobic character is retained. An appropriate 
length of segment M4 (14 or more amino acids) is 
required, however, for the expression of functional 
AChR on the cell surface. These results are consis- 
tent with the view that segment M4 traverses or is 
embedded in the membrane. The higher channel 
activities observed for the mutant AChRs contain- 
ing aMCIR, crM4-GP or aM4-15 with a substitu- 
tion or a deletion in segment M4 may reflect a 
higher open probability of the channel or also a 
larger elementary current; the apparent binding af- 
finity for carbamylcholine seems not to be substan- 
tially affected by these mutations (see the legend to 
table 1). 
Replacement of the hydrophobic segment Ml, 
M2 or M3 of the a-subunit by foreign hydrophobic 
transmembrane sequences, as well as an internal 
deletion in these segments, abolishes the cu-BTX 
binding activity on the cell surface and the ACh 
response, except that oocytes implanted with the 
mutant AChR containing cuM2-IR with a substitu- 
tion in segment M2 exhibit a reduced but signifi- 
cant cu-BTX binding activity on the cell surface. 
This observation suggests that these clustered 
hydrophobic segments, which presumably repre- 
sent transmembrane a-helices, are important for 
efficient expression of the AChR in the plasma 
membrane, possibly through their involvement in 
the correct folding, assembly or transport of the 
AChR subunits. It is also suggested that the 
specific amino acid sequence of segment M2 may 
be involved in channel activity, although the 
possibility that not all AChR subunits are express- 
ed on the cell surface cannot be excluded. In ac- 
cord with this notion is our study on the 
single-channel conductances of mutant AChRs 
with chimaeric &subunits, which suggests that a 
region comprising segment M2 and the adjacent 
bend portion between segments M2 and M3 is in- 
volved in determining the rate of ion transport 
through the channel [ 151. It has also been reported 
that segment M2 contributes to the binding site of 
noncompetitive antagonists [23,24]. 
Our results further show that the amphipathic 
segment MA of the a-subunit cannot be func- 
tionally replaced by foreign hydrophobic 
transmembrane sequences. On the other hand, 
deletion of part or all of segment MA of the cr- 
subunit strongly diminishes but does not abolish 
the ACh response and the a-BTX binding activity 
on the cell surface. This suggests that the am- 
phipathic segment MA is also important for effi- 
cient expression of the AChR in the plasma 
membrane. 
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